跳至主要内容
临床试验/NCT06471140
NCT06471140Enrolling By Invitation不适用

MRI Evaluation of Maternal Cardiovascular Response to Pregnancy in IVF Women Following Autologous Natural Cycle FET, Programmed FET and After Donor Embryo Transfer

Aalborg University Hospital1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2025年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
75
试验地点
1
主要终点
Maternal cardiovascular adaption to pregnancy

研究概览

简要总结

Aim of the study is to explore the effect of a lacking corpus luteum on maternal cardiovascular and metabolic adaption to pregnancy by the use of magnetic resonance imaging (MRI).

详细描述

The use of programmed frozen embryo transfer cycle (FET) in IVF women is associated with an increased risk of obstetric complications (pregnancy-induced hypertension, preeclampsia, postpartum hemorrhage and placenta accreta) compared to FET in natural cycle.

The lack of corpus luteum in programmed cycles and the subsequent absence of circulating vasoactive substances may lead to an impaired cardio-vascular adaption to pregnancy and thereby an increased risk of pregnancy-induced hypertension and preeclampsia.

The cardiovascular and metabolic adaption to pregnancy is evaluated throughout pregnancy by use of Magnetic Resonance Imaging (MRI) as well as non-invasive measurements by use of elastography and seismocardiography.

Patients are screened for preeclampsia throughout pregnancy with measurements of blood pressure, urine samples as well as blood samples.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Autologous embryo transfer in programmed FET-cycle or modified-natural FET-cycle or
  • Planned donor egg transfer in programmed FET-cycle or modified-natural FET-cycle
  • Age < 40 years
  • BMI < 35
  • Primary diagnosis being unexplained infertility, male infertility or tubal factor
  • Singleton blastocyst transfer

排除标准

  • Essential hypertension
  • Diabetes Mellitus (type 1 or 2)
  • Known cardiac disease
  • Antiphospholipid syndrome, Lupus erythematosus, rheumatoid disease
  • Preelampsia, gestational hypertension, gestational diabetes or severe intrauterine growth restriction (IUGR) in any previous pregnancy
  • Multiple pregnancy
  • Severe claustrophobia or any other contraindications to MRI

结局指标

主要结局

Maternal cardiovascular adaption to pregnancy

时间窗: From early pregnancy to six months postpartum

Placental function and fetal oxygenation estimated by longitudinal T2* weighted placental and fetal MRI

时间窗: From early pregnancy to six months postpartum

Maternal metabolic adaption to pregnancy

时间窗: From early pregnancy to six months postpartum

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lise Haaber Thomsen

MD, Consultant

Aalborg University Hospital

研究点 (1)

Loading locations...

相似试验

尚未招募
不适用
Biomarkers of CVD Dysfunction in Hypertensive Disorders of PregnancyCardiovascular DiseasesPregnancy
NCT05806372IRCCS Burlo Garofolo128
Unknown
不适用
Magnetic Resonance Imaging and Thermal Imaging of Adiposity in Neonates of Women With Metabolic DiseasesMetabolic DiseaseDiabetes MellitusIntrahepatic Cholestasis of Pregnancy
NCT04890886Guy's and St Thomas' NHS Foundation Trust80
已完成
不适用
Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasoneFetal cardiovascular status, and its correlation with neonatal outcome and long-term childhood neurosensory disability, following antenatal corticosteroids given to women at risk of preterm birth at less than 34 weeks gestationReproductive Health and Childbirth - Fetal medicine and complications of pregnancy
ACTRN12612000282886Dr Amanda Henry50
Unknown
不适用
Vascular Changes in Pre-Eclamptic Patients and Its Impact on Pregnancy Outcome.Pre-Eclampsia
NCT03111576Beni-Suef University100
进行中(未招募)
不适用
Maternal, uteroplacental and fetal haemodynamic effect of Nicardipine in severe pre-eclampsia. - CORCA IIHypertensive crisis in patients with severe pre-eclampsia needs to be treated to prevent maternal and fetal complications. The maternal, uteroplacental and fetal haemodynamic respose to antihypertensive treatment with Nicardipinehydrochloride will be evaluated in detail by materal echocardiography and fetal doppler ultrasound as well as by the effect on plasma Brain Natriuretic Peptide concentration (BNP) and parameters of the Renin- Angiotensin- Aldosterone system (RAAS).MedDRA version: 9.1Level: LLTClassification code 10040445Term: Severe pre-eclampsia, antepartumMedDRA version: 9.1Level: LLTClassification code 10053094Term: Doppler echocardiographyMedDRA version: 9.1Level: LLTClassification code 10045412Term: Ultrasound DopplerMedDRA version: 9.1Level: LLTClassification code 10058179Term: Hypertensive emergencyMedDRA version: 9.1Level: LLTClassification code 10038555Term: ReninMedDRA version: 9.1Level: LLTClassification code 10002491Term: Angiotensin IIMedDRA version: 9.1Level: LLTClassification code 10053406Term: Brain natriuretic peptideMedDRA version: 9.1Level: LLTClassification code 10001644Term: Aldosterone
EUCTR2007-000727-17-NLErasmus MC10